Remove 2030 Remove Assay Development Remove Marketing
article thumbnail

Six Factors for Biotech Companies to Consider When Choosing Next-Generation Contract GMP/CMC Laboratories

PPD

Continued expansion of the biotech industry is occurring in parallel, with an estimated compound annual growth rate of 13.96% from 2023-2030. 1 With this growth comes increased demands for laboratory services at all steps across the development process. Stay ahead of the curve with a great GMP/CMC contract laboratory partner.

article thumbnail

Advances in cell line development

Drug Discovery World

It is a crucial for the development of biopharmaceuticals since they use a living host to produce the therapeutic in question. The market for cell line development is currently rising due to an increased focus by the life sciences sector on biopharmaceuticals and targeted therapies.

Vaccine 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Early phase support for plasmid DNA supply to secure future manufacturing

Drug Discovery World

The market for cell and gene therapies has grown rapidly over the last few years and will likely continue, with forecasts predicting it will grow 39% to around $42.56 billion by 2030 (BioSpace, 11 August 2022).

DNA 130
article thumbnail

The evolution of assays for immuno-oncology research

Drug Discovery World

These have been the most promising form of antibodies being developed, with Ipilimumab (CTLA4 blocking) and Nivolumab (PD1 blocking) now approved by the US Food and Drug Administration (FDA) for more than nine cancer types. Strategic Market Research Report; Immuno-oncology Assays Market Size, Trend Analysis 2030.

Research 130